Annual report pursuant to Section 13 and 15(d)

Licenses Acquired (Journey and Other - Narrative) (Details)

v3.22.1
Licenses Acquired (Journey and Other - Narrative) (Details)
$ / shares in Units, $ in Thousands
12 Months Ended
Nov. 16, 2021
D
$ / shares
shares
Sep. 29, 2021
USD ($)
Jun. 29, 2021
USD ($)
Jun. 29, 2020
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Research and Development Arrangement, Contract to Perform for Others [Line Items]            
Research and development - licenses acquired         $ 15,625 $ 2,834
Licensing Agreements [Member]            
Research and Development Arrangement, Contract to Perform for Others [Line Items]            
Research and development - licenses acquired         15,625 2,834
Journey [Member] | Dr. Reddy's Laboratories, Ltd [Member]            
Research and Development Arrangement, Contract to Perform for Others [Line Items]            
Payments of milestones       $ 4,000    
Journey [Member] | Dr. Reddy's Laboratories, Ltd [Member] | Achievement of Certain Sales Milestones [Member]            
Research and Development Arrangement, Contract to Perform for Others [Line Items]            
Payments of milestones       $ 17,000    
Journey [Member] | Licensing Agreements [Member]            
Research and Development Arrangement, Contract to Perform for Others [Line Items]            
Research and development - licenses acquired         13,819 $ 0
Journey [Member] | Licensing Agreements [Member] | Dr. Reddy's Laboratories, Ltd [Member]            
Research and Development Arrangement, Contract to Perform for Others [Line Items]            
Upfront fees payment     $ 10,000      
Payments of milestones   $ 8,000 2,000      
Maintenance fees     24,000      
Shares issued, price per share | $ / shares $ 9.1721          
Stock Issued During Period, Shares, New Issues | shares 545,131          
Number of trading days for calculating volume weighted average price per share | D 15          
Journey [Member] | Licensing Agreements [Member] | Dr. Reddy's Laboratories, Ltd [Member] | Contingent Payment Warrant [Member]            
Research and Development Arrangement, Contract to Perform for Others [Line Items]            
Warrants, fair value         $ 3,800  
Journey [Member] | Licensing Agreements [Member] | Dr. Reddy's Laboratories, Ltd [Member] | Achievement of Certain Clinical Development, Regulatory and First Commercial Sale milestones [Member]            
Research and Development Arrangement, Contract to Perform for Others [Line Items]            
Payments of milestones     $ 163,000      
Journey [Member] | Licensing Agreements [Member] | Minimum [Member] | Dr. Reddy's Laboratories, Ltd [Member] | Payable on Net Sales of the DFD-29 Product [Member]            
Research and Development Arrangement, Contract to Perform for Others [Line Items]            
Sales royalties (as a percent)     10.00%      
Journey [Member] | Licensing Agreements [Member] | Maximum [Member] | Dr. Reddy's Laboratories, Ltd [Member] | Payable on Net Sales of the DFD-29 Product [Member]            
Research and Development Arrangement, Contract to Perform for Others [Line Items]            
Sales royalties (as a percent)     15.00%